RA

Robert Alonso

Founder & CEO

Mitochon Pharmaceuticals

Mitochon Pharmaceuticals Pipeline

DrugIndicationPhase
MP-101Multiple Indications (Neurodegenerative)Preclinical
MP-201Multiple Indications (Neurodegenerative)Preclinical